Microbiome Focus Pendulum Therapeutics specializes in microbiome-targeted interventions, offering a unique selling proposition in the biotechnology research industry.
Market Positioning Among similar companies, Pendulum falls within the mid-range for employee size and revenue, indicating potential growth opportunities and scalability for collaboration.
Financial Standing With estimated revenue between $10M and $50M, Pendulum's financial health suggests a stable foundation for prospective business partnerships and product development collaborations.
Industry Partnerships Exploring strategic partnerships with Pendulum could leverage their expertise in microbiome formulations to enhance product portfolios and enter new markets more effectively.
Innovative Solutions Pendulum's commitment to developing novel bacterial strains for microbiome rebalancing presents an opportunity for companies seeking cutting-edge solutions in biotechnology and healthcare.
$10M$50M
$10M$50M
$10M$50M
$10M
$10M
$10M
$50M$100M| Pendulum Therapeutics Email Formats | Percentage |
| First.Last@wholebiome.com | 99% |
| FL@wholebiome.com | 1% |
| First.Last@pendulum.co | 91% |
| Last@pendulum.co | 9% |
Biotechnology ResearchCalifornia, United States51-200 Employees
Pendulum is committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases. Our targeted formulations of natural bacterial strains help to rebalance the microbiome which restores and improve one’s health.
Company Overview
Funding & FinancialsPendulum Therapeutics's revenue is in the range of $10M$50M
Funding & FinancialsPendulum Therapeutics's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com